Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dual inhibitors of enkephalin-degrading enzymes (neutral endopeptidase 24.11 and aminopeptidase N) as potential new medications in the management of pain and opioid addiction.

× No keyword cloud information.

12 in total

1. Exploring the Backbone of Enkephalins To Adjust Their Pharmacological Profile for the δ-Opioid Receptor.

Authors: Arnaud Proteau-Gagné; Véronique Bournival; Kristina Rochon; Yves L Dory; Louis Gendron
Journal: ACS Chem Neurosci Date: 2010-09-17 Impact factor: 4.418

2. Preparation and evaluation at the delta opioid receptor of a series of linear leu-enkephalin analogues obtained by systematic replacement of the amides.

Authors: Kristina Rochon; Arnaud Proteau-Gagné; Philippe Bourassa; Jean-François Nadon; Jérome Côté; Véronique Bournival; Fernand Gobeil; Brigitte Guérin; Yves L Dory; Louis Gendron
Journal: ACS Chem Neurosci Date: 2013-05-20 Impact factor: 4.418

Review 3. Novel neuropeptides as ligands of orphan G protein-coupled receptors.

Authors: Yan Zhang; Zhiwei Wang; Gregory Scott Parks; Olivier Civelli
Journal: Curr Pharm Des Date: 2011 Impact factor: 3.116

4. Similar decrease in spontaneous morphine abstinence by methadone and RB 101, an inhibitor of enkephalin catabolism.

Authors: F Ruiz; M C Fournié-Zaluski; B P Roques; R Maldonado
Journal: Br J Pharmacol Date: 1996-09 Impact factor: 8.739

5. Synthesis and Opioid Activity of Tyr¹ -ψ[(Z)CF=CH]-Gly² and Tyr¹ -ψ[(S)/(R)-CF₃ CH-NH]-Gly² Leu-enkephalin Fluorinated Peptidomimetics.

Authors: Somnath Narayan Karad; Mohan Pal; Rachel S Crowley; Thomas E Prisinzano; Ryan A Altman
Journal: ChemMedChem Date: 2017-04-05 Impact factor: 3.466

6. Blockade of morphine-induced behavioral sensitization by a combination of amisulpride and RB101, comparison with classical opioid maintenance treatments.

Authors: L Cordonnier; M Sanchez; B P Roques; F Noble
Journal: Br J Pharmacol Date: 2007-03-12 Impact factor: 8.739

Review 7. Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction.

Authors: B P Roques; F Noble
Journal: Neurochem Res Date: 1996-11 Impact factor: 3.996

Dual inhibitors of enkephalin-degrading enzymes (neutral endopeptidase 24.11 and aminopeptidase N) as potential new medications in the management of pain and opioid addiction.